Cellectar Biosciences INC NEW (CLRB) is a publicly traded Healthcare sector company. As of November 10, 2026, CLRB trades at $1.22 with a market cap of $11.82M and a P/E ratio of -0.17. CLRB moved -5.00% today. Year to date, CLRB is -62.91%; over the trailing twelve months it is -62.04%. Its 52-week range spans $1.11 to $20.59. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces CLRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CLRB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLRB recently traded at $1.22. Market cap is $11.82M. P/E ratio is -0.17. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.22 |
| Market Cap | $11.82M |
| P/E Ratio |
| -0.17 |
| EPS | $-8.35 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $20.59 |
|---|
| 52-Week Low | $1.11 |
|---|
| Volume | 2.96K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $-21.79M |
|---|
| Gross Margin | 0.00% |
|---|
2 analysts cover CLRB: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.